United Kingdom· GB-APID-28979411000001105
Recombinant human hyaluronidase solution for infusion 1.25ml vials
A hyaluronidase product containing hyaluronidase, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 7 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Hyaluronidase is registered in 7 of 19 countries.
Countries holding a registration under ATC B06AA03 (hyaluronidase), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Hyaluronidase · ATC B06AA03
7 / 19 countries
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Hyaluronidase
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- B06AA03
- ATC class
- Hyaluronidase
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
84 interactions on record for hyaluronidase.
Graded by severity as the source publishes them — 84 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyaluronidase · interactions on record
84 records
Same medicine, other countries
Hyaluronidase in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayHyaluronidase wockhardtWockhardt
- GermanyHylase „dessau“Esteve Pharmaceuticals Gmbh
- IrelandHyaluronidase 1500 I.U. Powder for Solution for Injection or InfusionPinewood Laboratories Ltd
- NetherlandsHyason 150 I.E., poeder voor injectievloeistofEsteve Pharmaceuticals GmbH
- United StatesAMPHADASEAmphastar Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Austria · Hylase Dessau
- Germany · Hylase Dessau
- Ireland · Hyaluronidase Pinewood Laboratories
- Malta · Hyalase
- Netherlands · Hyason
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d20e14f0-bdff-423f-afed-e8cce83d85f9 GET /v1/drugs/d20e14f0-bdff-423f-afed-e8cce83d85f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "28979411000001105",
"desc": "Recombinant human hyaluronidase solution for infusion 1.25ml vials (Takeda UK Ltd)",
"form": "Solution for infusion",
"vpid": "28990411000001109",
"source": "dmd",
"vtm_id": null,
"strength": null,
"substance": null,
"ingredient": "Hyaluronidase",
"supplier_code": "3811601000001107"
}See everything about hyaluronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.